{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:39:08Z","timestamp":1792179548595,"version":"4.4.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22077110"],"award-info":[{"award-number":["22077110"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32100577"],"award-info":[{"award-number":["32100577"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20200106"],"award-info":[{"award-number":["BK20200106"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010023","name":"Natural Science Research of Jiangsu Higher Education Institutions of China","doi-asserted-by":"publisher","award":["20KJA350001"],"award-info":[{"award-number":["20KJA350001"]}],"id":[{"id":"10.13039\/501100010023","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018636","name":"Xuzhou Science and Technology Program","doi-asserted-by":"publisher","award":["KC21053"],"award-info":[{"award-number":["KC21053"]}],"id":[{"id":"10.13039\/501100018636","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.bcp.2022.115355","type":"journal-article","created":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T05:13:47Z","timestamp":1669353227000},"page":"115355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Inhibition of deubiquitinase USP28 attenuates cyst growth in autosomal dominant polycystic kidney disease"],"prefix":"10.1016","volume":"207","author":[{"given":"Ying","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kequan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yupeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bcp.2022.115355_b0005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2015.59","article-title":"Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"88","author":"Chapman","year":"2015","journal-title":"Kidney Int."},{"issue":"9","key":"10.1016\/j.bcp.2022.115355_b0010","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41575-022-00617-7","article-title":"Genetics, pathobiology and therapeutic opportunities of polycystic liver disease","volume":"19","author":"Olaizola","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"10174","key":"10.1016\/j.bcp.2022.115355_b0015","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(18)32782-X","article-title":"Autosomal dominant polycystic kidney disease","volume":"393","author":"Cornec-Le Gall","year":"2019","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.bcp.2022.115355_b0020","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0272-6386(12)80507-5","article-title":"Polycystic kidney disease: neoplasia in disguise","volume":"15","author":"Grantham","year":"1990","journal-title":"Am. J. Kidney Dis."},{"issue":"9","key":"10.1016\/j.bcp.2022.115355_b0025","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nrneph.2015.46","article-title":"The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease","volume":"11","author":"Seeger-Nukpezah","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"10.1016\/j.bcp.2022.115355_b0030","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1146\/annurev-biochem-061516-044916","article-title":"Mechanisms of Deubiquitinase Specificity and Regulation","volume":"86","author":"Mevissen","year":"2017","journal-title":"Annu. Rev. Biochem"},{"issue":"4","key":"10.1016\/j.bcp.2022.115355_b0035","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1172\/JCI22850","article-title":"Pkd1 regulates immortalized proliferation of renal tubular epithelial cells through p53 induction and JNK activation","volume":"115","author":"Nishio","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.bcp.2022.115355_b0040","doi-asserted-by":"crossref","first-page":"6911","DOI":"10.1002\/jcp.26473","article-title":"MicroRNA501-5p induces p53 proteasome degradation through the activation of the mTOR\/MDM2 pathway in ADPKD cells","volume":"233","author":"de Stephanis","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bcp.2022.115355_b0045","doi-asserted-by":"crossref","first-page":"109594","DOI":"10.1016\/j.cellsig.2020.109594","article-title":"The master regulators Myc and p53 cellular signaling and functions in polycystic kidney disease","volume":"71","author":"Kurbegovic","year":"2020","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bcp.2022.115355_b0050","doi-asserted-by":"crossref","first-page":"109644","DOI":"10.1016\/j.cellsig.2020.109644","article-title":"Post-translational modifications of the polycystin proteins","volume":"72","author":"Streets","year":"2020","journal-title":"Cell. Signal."},{"issue":"11","key":"10.1016\/j.bcp.2022.115355_b0055","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/hmg\/ddn039","article-title":"Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1","volume":"17","author":"Shibazaki","year":"2008","journal-title":"Hum Mol Genet"},{"issue":"13","key":"10.1016\/j.bcp.2022.115355_b0060","doi-asserted-by":"crossref","first-page":"9295","DOI":"10.1021\/acs.jmedchem.2c00567","article-title":"Benzodiazepine Derivatives as Potent Vasopressin V2 Receptor Antagonists for the Treatment of Autosomal Dominant Kidney Disease","volume":"65","author":"Cao","year":"2022","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bcp.2022.115355_b0065","doi-asserted-by":"crossref","first-page":"7717","DOI":"10.1021\/acs.jmedchem.2c00011","article-title":"Long Residence Time at the Vasopressin V2 Receptor Translates into Superior Inhibitory Effects in Ex Vivo and In Vivo Models of Autosomal Dominant Polycystic Kidney Disease","volume":"65","author":"Zhang","year":"2022","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bcp.2022.115355_b0070","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s42255-020-0227-4","article-title":"Super-enhancer-driven metabolic reprogramming promotes cystogenesis in autosomal dominant polycystic kidney disease","volume":"2","author":"Mi","year":"2020","journal-title":"Nat Metab"},{"issue":"8","key":"10.1016\/j.bcp.2022.115355_b0075","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.3390\/ijms22083918","article-title":"Modeling Neoplastic Growth in Renal Cell Carcinoma and Polycystic Kidney Disease","volume":"22","author":"Millet-Boureima","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2022.115355_b0080","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10157-016-1289-1","article-title":"Double inhibition of cAMP and mTOR signalling may potentiate the reduction of cell growth in ADPKD cells","volume":"21","author":"de Stephanis","year":"2017","journal-title":"Clin. Exp. Nephrol."},{"issue":"6","key":"10.1016\/j.bcp.2022.115355_b0085","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.kint.2017.04.013","article-title":"Ganoderma triterpenes retard renal cyst development by downregulating Ras\/MAPK signaling and promoting cell differentiation","volume":"92","author":"Su","year":"2017","journal-title":"Kidney Int."},{"issue":"8","key":"10.1016\/j.bcp.2022.115355_b0090","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrd4088","article-title":"Therapeutic modulators of STAT signalling for human diseases","volume":"12","author":"Miklossy","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"issue":"12","key":"10.1016\/j.bcp.2022.115355_b0095","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1021\/acschembio.7b00334","article-title":"Identification and Characterization of Dual Inhibitors of the USP25\/28 Deubiquitinating Enzyme Subfamily","volume":"12","author":"Wrigley","year":"2017","journal-title":"ACS Chem. Biol."},{"issue":"21","key":"10.1016\/j.bcp.2022.115355_b0100","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1093\/hmg\/ddr338","article-title":"Pyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways","volume":"20","author":"Takakura","year":"2011","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1016\/j.bcp.2022.115355_b0105","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/emboj\/18.3.717","article-title":"Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc","volume":"18","author":"Salghetti","year":"1999","journal-title":"EMBO J."},{"issue":"11","key":"10.1016\/j.bcp.2022.115355_b0110","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1038\/nm.3739","article-title":"Ubiquitination in disease pathogenesis and treatment","volume":"20","author":"Popovic","year":"2014","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.bcp.2022.115355_b0115","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrd.2017.152","article-title":"Deubiquitylating enzymes and drug discovery: emerging opportunities","volume":"17","author":"Harrigan","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.bcp.2022.115355_b0120","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.molcel.2021.10.027","article-title":"Deubiquitinases: From mechanisms to their inhibition by small molecules","volume":"82","author":"Lange","year":"2022","journal-title":"Mol. Cell"},{"issue":"8","key":"10.1016\/j.bcp.2022.115355_b0125","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1097\/01.ASN.0000133490.00348.59","article-title":"Siah-1 interacts with the intracellular region of polycystin-1 and affects its stability via the ubiquitin-proteasome pathway","volume":"15","author":"Kim","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"18","key":"10.1016\/j.bcp.2022.115355_b0130","doi-asserted-by":"crossref","first-page":"6383","DOI":"10.1128\/MCB.00254-07","article-title":"TAZ promotes PC2 degradation through a SCFbeta-Trcp E3 ligase complex","volume":"27","author":"Tian","year":"2007","journal-title":"Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.bcp.2022.115355_b0135","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/hmg\/ddy380","article-title":"The deubiquitinating enzyme Usp14 controls ciliogenesis and Hedgehog signaling","volume":"28","author":"Massa","year":"2019","journal-title":"Hum Mol Genet"},{"issue":"8","key":"10.1016\/j.bcp.2022.115355_b0140","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1681\/ASN.2013091026","article-title":"The cleaved cytoplasmic tail of polycystin-1 regulates Src-dependent STAT3 activation","volume":"25","author":"Talbot","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"19","key":"10.1016\/j.bcp.2022.115355_b0145","doi-asserted-by":"crossref","first-page":"7985","DOI":"10.1073\/pnas.1103816108","article-title":"Polycystin-1 regulates STAT activity by a dual mechanism","volume":"108","author":"Talbot","year":"2011","journal-title":"PNAS"},{"issue":"10","key":"10.1016\/j.bcp.2022.115355_b0150","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-021-04248-9","article-title":"The tyrosine-kinase inhibitor Nintedanib ameliorates autosomal-dominant polycystic kidney disease","volume":"12","author":"Jamadar","year":"2021","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bcp.2022.115355_b0155","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1038\/s41598-019-41106-3","article-title":"Renal expression of JAK2 is high in polycystic kidney disease and its inhibition reduces cystogenesis","volume":"9","author":"Patera","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2022.115355_b0160","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41571-021-00549-2","article-title":"The MYC oncogene - the grand orchestrator of cancer growth and immune evasion","volume":"19","author":"Dhanasekaran","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.bcp.2022.115355_b0165","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nrc.2017.36","article-title":"Drugging the 'undruggable' cancer targets","volume":"17","author":"Dang","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.bcp.2022.115355_b0170","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/ki.1991.80","article-title":"C-myc as an inducer of polycystic kidney disease in transgenic mice","volume":"39","author":"Trudel","year":"1991","journal-title":"Kidney Int."},{"issue":"46","key":"10.1016\/j.bcp.2022.115355_b0175","doi-asserted-by":"crossref","first-page":"29001","DOI":"10.1073\/pnas.2009334117","article-title":"TAZ\/Wnt-beta-catenin\/c-MYC axis regulates cystogenesis in polycystic kidney disease","volume":"117","author":"Lee","year":"2020","journal-title":"PNAS"},{"issue":"11-12","key":"10.1016\/j.bcp.2022.115355_b0180","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1101\/gad.315127.118","article-title":"A RhoA-YAP-c-Myc signaling axis promotes the development of polycystic kidney disease","volume":"32","author":"Cai","year":"2018","journal-title":"Genes Dev."},{"issue":"6","key":"10.1016\/j.bcp.2022.115355_b0185","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/ki.2014.427","article-title":"Glycogen synthase kinase-3beta promotes cyst expansion in polycystic kidney disease","volume":"87","author":"Tao","year":"2015","journal-title":"Kidney Int."},{"issue":"7","key":"10.1016\/j.bcp.2022.115355_b0190","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1172\/JCI64401","article-title":"Sirtuin 1 inhibition delays cyst formation in autosomal-dominant polycystic kidney disease","volume":"123","author":"Zhou","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bcp.2022.115355_b0195","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1046\/j.1523-1755.2002.0610s1125.x","article-title":"c-myc antisense oligonucleotide treatment ameliorates murine ARPKD","volume":"61","author":"Ricker","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.bcp.2022.115355_b0200","article-title":"Ubiquitin-Specific Protease 25 Aggravates Acute Pancreatitis and Acute Pancreatitis-Related Multiple Organ Injury by Destroying Tight Junctions Through Activation of The STAT3 Pathway","volume":"9","author":"Liu","year":"2021","journal-title":"Front. Cell Dev. Biol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295222004506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295222004506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:15:02Z","timestamp":1762096502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295222004506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":40,"alternative-id":["S0006295222004506"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2022.115355","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of deubiquitinase USP28 attenuates cyst growth in autosomal dominant polycystic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2022.115355","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115355"}}